GrayMatters Health Launches Prism Imagine To Connect Psychiatry Clinics With Consumers

GrayMatters Health announced the launch of Prism Imagine, a generative artificial intelligence (AI) tool for psychiatric clinics that provide interventional treatments.

The tool allows consumers to enter a brief description of a mental strategy they use during Prism sessions. Prism Imagine then generates a visual representation of that strategy, which consumers can refine, save, and review between sessions or after treatment. Consumers may also share the image with other members of their care team.

The Prism platform uses digital biomarkers informed by functional magnetic resonance imaging (fMRI) to help consumers identify mental strategies associated with changes in brain activity. Consumers . . .